Elicio Therapeutics Stock (NASDAQ: ELTX) stock price, news, charts, stock research, profile.
Open | $4.47 |
Close | $4.34 |
Volume / Avg. | 7.41K / 37.01K |
Day Range | $4.30 - $4.47 |
52 Wk Range | 2.96 - 11.45 |
Market Cap | $46.44M |
P/E Ratio | 4.85 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.78% |
Days to Cover | 2.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elicio Therapeutics (NASDAQ:ELTX) through any online brokerage.
Other companies in Elicio Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), HOOKIPA Pharma (NASDAQ:HOOK), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR) and Estrella Immunopharma (NASDAQ:ESLA).
Elicio Therapeutics has a consensus price target of $10.00.
The stock price for Elicio Therapeutics (NASDAQ: ELTX) is $4.31 last updated August 22, 2024 at 8:11 AM EDT.
There are no upcoming dividends for Elicio Therapeutics.
Elicio Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Elicio Therapeutics.
Elicio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.